Post-marketing surveillance of tepotinib for non-small cell lung cancer with MET exon 14 skipping mutations e final reportTerufumi Kato, Tatsuya Ogura,Masashi Sato,Risa Kojima, Bingbing Song, Eisuke Horii,Kazuhiko NakagawaANNALS OF ONCOLOGY（2023）引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
